Keyan Salari MD PhD

Surgical Oncology

Urologic Oncologist, Massachusetts General Hospital

Massachusetts General Hospital55 Fruit St., GRB-1109ABoston, MA 02114

Dr. Salari is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Salari's full profile Already have an account?

Summary

Dr. Keyan Salari is a urologic oncologist in Boston, MA and is affiliated with Massachusetts General Hospital and Harvard Medical School. He received his medical degree from Stanford University School of Medicine and trained at Massachusetts General Hospital and Memorial Sloan Kettering Cancer Center. He has been in practice 7 years. He is experienced in urology, oncology, and cancer genomics.

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2018 - 2019
Mass General Brigham/Massachusetts General Hospital/Harvard Medical SchoolResidency, Urology, 2014 - 2018
Mass General Brigham/Massachusetts General HospitalInternship, Surgery, 2012 - 2013
Stanford University School of MedicineClass of 2012, M.D.
Stanford UniversityPh.D., Genetics, 2010

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2012 - 2028
ME State Medical License 2020 - 2028
RI State Medical License 2021 - 2028
NH State Medical License 2021 - 2027
NY State Medical License 2017 - 2019
American Board of Urology Urology

Publications & Presentations

PubMed

Noninvasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison with MRI.
Jeffrey J Tosoian, Jacob I Meyers, Bradley Moore, Cameron J Britton, Kent Chevli
The Journal of Urology. 2026-09-01
Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer.
David D Yang, Aya Abdelnaser, Alexander J Haas, Jeremiah Wala, Alfred A Barney
Clinical Cancer Research. 2026-08-14
Molecular and Genetic Insights for Personalized Treatment of Non-Muscle-Invasive Bladder Cancer.
Jose I Nolazco, Kendrick Yim, Keyan Salari
The Urologic Clinics of North America. 2026-08-01

Journal Articles

Detection of Pathogenic Variants with Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients with Prostate Cancer and Melanoma
Keyan Salari, MD, JAMA

Press Mentions

Genomic Urine Test Detects Bladder Cancer from DNA up to 12 Years Before Clinical Signs and Symptoms AppearMay 1st, 2023
Role of HRD in Early-Stage Prostate CancerMay 31st, 2022
Metabolic Syndrome Post-Prostatectomy Ups Prostate Cancer Death RiskSeptember 12th, 2021